Weight gain, body mass index, hormone replacement therapy, and postmenopausal breast cancer in a large prospective study.

@article{Feigelson2004WeightGB,
  title={Weight gain, body mass index, hormone replacement therapy, and postmenopausal breast cancer in a large prospective study.},
  author={Heather Spencer Feigelson and Carolyn R. Jonas and Lauren R. Teras and Michael J. Thun and Eugenia E. Calle},
  journal={Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology},
  year={2004},
  volume={13 2},
  pages={220-4}
}
Excess adiposity and hormone replacement therapy (HRT) are important contributors to postmenopausal breast cancer risk. HRT has been shown to modify the association between body weight and breast cancer risk, although few studies are sufficiently large to examine the risk of breast cancer associated with body mass index (BMI) and weight gain separately among current HRT users and nonusers. This study includes 1,934 incident breast cancer cases occurring among 62,756 postmenopausal women in the… CONTINUE READING